BioSante second quarter net loss increases to $15.

BioSante second quarter net loss increases to $15 http://tadalafilusa.com/the-most-common-questions-about-cialis.html .0 million BioSante Pharmaceuticals, Inc. today announced its economic results for the next quarter of 2011. THE BUSINESS’S cash and money equivalents by June 30, 2011 had been around $37.1 million. BioSante incurred a net lack of around $15.0 million or per talk about for the one fourth ended June 30, 2011, in comparison to a net lack of $10.8 million or per talk about for the same period this year 2010.S.

Related Posts

Other Posts From Category "diagnostics":